FDA agrees to review Moderna’s mRNA flu vaccine after Trump’s vaccine chief initially rejected it by overruling career scientists who recommended the application proceed.
Companies abandoning vaccine research, cutting jobs
Read the full story at Ars Technica
From the February 18, 2026 GovBrief, every story that day in one place.